1. Home
  2. PHGE vs SCOR Comparison

PHGE vs SCOR Comparison

Compare PHGE & SCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • SCOR
  • Stock Information
  • Founded
  • PHGE 2015
  • SCOR 1999
  • Country
  • PHGE Israel
  • SCOR United States
  • Employees
  • PHGE N/A
  • SCOR N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • SCOR Business Services
  • Sector
  • PHGE Health Care
  • SCOR Consumer Discretionary
  • Exchange
  • PHGE Nasdaq
  • SCOR Nasdaq
  • Market Cap
  • PHGE 26.5M
  • SCOR 27.2M
  • IPO Year
  • PHGE N/A
  • SCOR 2007
  • Fundamental
  • Price
  • PHGE $0.49
  • SCOR $7.65
  • Analyst Decision
  • PHGE Strong Buy
  • SCOR Buy
  • Analyst Count
  • PHGE 2
  • SCOR 3
  • Target Price
  • PHGE $22.50
  • SCOR $12.83
  • AVG Volume (30 Days)
  • PHGE 159.9K
  • SCOR 39.8K
  • Earning Date
  • PHGE 11-14-2024
  • SCOR 11-12-2024
  • Dividend Yield
  • PHGE N/A
  • SCOR N/A
  • EPS Growth
  • PHGE N/A
  • SCOR N/A
  • EPS
  • PHGE N/A
  • SCOR N/A
  • Revenue
  • PHGE N/A
  • SCOR $356,212,000.00
  • Revenue This Year
  • PHGE N/A
  • SCOR N/A
  • Revenue Next Year
  • PHGE N/A
  • SCOR $3.32
  • P/E Ratio
  • PHGE N/A
  • SCOR N/A
  • Revenue Growth
  • PHGE N/A
  • SCOR N/A
  • 52 Week Low
  • PHGE $0.49
  • SCOR $4.89
  • 52 Week High
  • PHGE $8.55
  • SCOR $20.97
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 21.78
  • SCOR 64.14
  • Support Level
  • PHGE $0.56
  • SCOR $7.04
  • Resistance Level
  • PHGE $0.79
  • SCOR $7.69
  • Average True Range (ATR)
  • PHGE 0.10
  • SCOR 0.76
  • MACD
  • PHGE -0.02
  • SCOR 0.25
  • Stochastic Oscillator
  • PHGE 0.00
  • SCOR 67.32

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

About SCOR comScore Inc.

comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. The platforms measure include televisions, mobile devices, computers, tablets, CTV devices and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada and Others. It provides solutions for Automotive, Digital Media, Financial Services, FMCG, Pharmaceutical , Retail, Technology and Travel.

Share on Social Networks: